is jili games legit

is jili games legit Tesla bet on shareholder ‘ratification’ to save Musk’s pay package. It lost the bet.BETHESDA, Md. , Dec. 11, 2024 /PRNewswire/ -- AGNC Investment Corp. (Nasdaq: AGNC) announced today that its Board of Directors has declared a cash dividend of $0.12 per share of common stock for December 2024 . The dividend is payable on January 10, 2025 to common stockholders of record as of December 31, 2024 . For further information or questions, please contact Investor Relations at (301) 968-9300 or IR@AGNC.com . ABOUT AGNC INVESTMENT CORP. Founded in 2008, AGNC Investment Corp. (Nasdaq: AGNC) is a leading investor in Agency residential mortgage-backed securities (Agency MBS), which benefit from a guarantee against credit losses by Fannie Mae, Freddie Mac, or Ginnie Mae . We invest on a leveraged basis, financing our Agency MBS assets primarily through repurchase agreements, and utilize dynamic risk management strategies intended to protect the value of our portfolio from interest rate and other market risks. AGNC has a track record of providing favorable long-term returns for our stockholders through substantial monthly dividend income, with over $13 billion of common stock dividends paid since inception. Our business is a significant source of private capital for the U.S. residential housing market, and our team has extensive experience managing mortgage assets across market cycles. To learn more about The Premier Agency Residential Mortgage REIT , please visit www.AGNC.com , follow us on LinkedIn and X , and sign up for Investor Alerts . CONTACT: Investor Relations - (301) 968-9300 View original content: https://www.prnewswire.com/news-releases/agnc-investment-corp-declares-monthly-common-stock-dividend-of-0-12-per-common-share-for-december-2024--302329440.html SOURCE AGNC Investment Corp.

The people that president-elect Donald Trump has selected to lead federal health agencies in his second administration include a retired congressman, a surgeon and a former talk-show host. All of them could play pivotal roles in fulfilling a new political agenda that could change how the government goes about safeguarding Americans' health — from health care and medicines to food safety and science research. And if Congress approves, at the helm of the team as Department of Health and Human Services secretary will be prominent environmental lawyer and anti-vaccine organizer Robert F. Kennedy Jr. By and large, the nominees don't have experience running large bureaucratic agencies, but they know how to talk about health on TV . Centers for Medicare and Medicaid pick Dr. Mehmet Oz hosted a talk show for 13 years and is a well-known wellness and lifestyle influencer. The pick for the Food and Drug Administration, Dr. Marty Makary, and for surgeon general, Dr. Janette Nesheiwat, are frequent Fox News contributors. Many on the list were critical of COVID-19 measures like masking and booster vaccinations for young people. Some of them have ties to Florida like many of Trump's other Cabinet nominees: CDC pick Dr. Dave Weldon represented the state in Congress for 14 years and is affiliated with a medical group on the state's Atlantic coast. Nesheiwat's brother-in-law is Rep. Mike Waltz , R-Fla., tapped by Trump as national security adviser. Here's a look at the nominees' potential role in carrying out what Kennedy says is the task to “reorganize” agencies, which have an overall $1.7 billion budget; employ 80,000 scientists, researchers, doctors and other officials; and affect the lives of all Americans. Centers for Disease Control and Prevention The Atlanta-based CDC, with a $9.2 billion core budget, is charged with protecting Americans from disease outbreaks and other public health threats. Kennedy has long attacked vaccines and criticized the CDC, repeatedly alleging corruption at the agency. He said on a 2023 podcast that there is "no vaccine that is safe and effective,” and urged people to resist the CDC's guidelines on if and when kids should get vaccinated . Decades ago, Kennedy found common ground with Weldon , the 71-year-old nominee to run the CDC who served in the Army and worked as an internal medicine doctor before he represented a central Florida congressional district from 1995 to 2009. Starting in the early 2000s, Weldon had a prominent part in a debate about whether there was a relationship between a vaccine preservative called thimerosal and autism. He was a founding member of the Congressional Autism Caucus and tried to ban thimerosal from all vaccines. Kennedy, then a senior attorney for the Natural Resources Defense Council, believed there was a tie between thimerosal and autism and also charged that the government hid documents showing the danger. Since 2001, all vaccines manufactured for the U.S. market and routinely recommended for children 6 years or younger have contained no thimerosal or only trace amounts, with the exception of inactivated influenza vaccine. Meanwhile, study after study after study found no evidence that thimerosal caused autism. Weldon's congressional voting record suggests he may go along with Republican efforts to downsize the CDC, including to eliminate the National Center for Injury Prevention and Control, which works on topics like drownings, drug overdoses and shooting deaths. Weldon also voted to ban federal funding for needle-exchange programs as an approach to reduce overdoses, and the National Rifle Association gave him an “A” rating for his pro-gun rights voting record. Food and Drug Administration Kennedy is extremely critical of the FDA, which has 18,000 employees and is responsible for the safety and effectiveness of prescription drugs, vaccines and other medical products — as well as overseeing cosmetics, electronic cigarettes and most foods. Makary, Trump’s pick to run the FDA, is closely aligned with Kennedy on several topics . The professor at Johns Hopkins University who is a trained surgeon and cancer specialist has decried the overprescribing of drugs, the use of pesticides on foods and the undue influence of pharmaceutical and insurance companies over doctors and government regulators. Kennedy has suggested he'll clear our “entire” FDA departments and also recently threatened to fire FDA employees for “aggressive suppression” of a host of unsubstantiated products and therapies, including stem cells, raw milk , psychedelics and discredited COVID-era treatments like ivermectin and hydroxychloroquine. Makary's contrarian views during the COVID-19 pandemic including the need for masking and giving young kids COVID vaccine boosters. But anything Makary and Kennedy might want to do when it comes to unwinding FDA regulations or revoking long-standing vaccine and drug approvals would be challenging. The agency has lengthy requirements for removing medicines from the market, which are based on federal laws passed by Congress. Centers for Medicaid and Medicare Services The agency provides health care coverage for more than 160 million people through Medicaid, Medicare and the Affordable Care Act, and also sets Medicare payment rates for hospitals, doctors and other providers. With a $1.1 trillion budget and more than 6,000 employees, Oz has a massive agency to run if confirmed — and an agency that Kennedy hasn't talked about much when it comes to his plans. While Trump tried to scrap the Affordable Care Act in his first term, Kennedy has not taken aim at it yet. But he has been critical of Medicaid and Medicare for covering expensive weight-loss drugs — though they're not widely covered by either . Trump said during his campaign that he would protect Medicare, which provides insurance for older Americans. Oz has endorsed expanding Medicare Advantage — a privately run version of Medicare that is popular but also a source of widespread fraud — in an AARP questionnaire during his failed 2022 bid for a U.S. Senate seat in Pennsylvania and in a 2020 Forbes op-ed with a former Kaiser Permanente CEO. Oz also said in a Washington Examiner op-ed with three co-writers that aging healthier and living longer could help fix the U.S. budget deficit because people would work longer and add more to the gross domestic product. Neither Trump nor Kennedy have said much about Medicaid, the insurance program for low-income Americans. Trump's first administration reshaped the program by allowing states to introduce work requirements for recipients. Surgeon general Kennedy doesn't appear to have said much publicly about what he'd like to see from surgeon general position, which is the nation's top doctor and oversees 6,000 U.S. Public Health Service Corps members. The surgeon general has little administrative power, but can be an influential government spokesperson on what counts as a public health danger and what to do about it — suggesting things like warning labels for products and issuing advisories. The current surgeon general, Vivek Murthy, declared gun violence as a public health crisis in June. Trump's pick, Nesheiwat, is employed as a New York City medical director with CityMD, a group of urgent care facilities in the New York and New Jersey area, and has been at City MD for 12 years. She also has appeared on Fox News and other TV shows, authored a book on the “transformative power of prayer” in her medical career and endorses a brand of vitamin supplements. She encouraged COVID-19 vaccines during the pandemic, calling them “a gift from God” in a February 2021 Fox News op-ed, as well as anti-viral pills like Paxlovid. In a 2019 Q&A with the Women in Medicine Legacy Foundation , Nesheiwat said she is a “firm believer in preventive medicine” and “can give a dissertation on hand-washing alone.” National Institutes of Health As of Saturday, Trump had not yet named his choice to lead the National Institutes of Health, which funds medical research through grants to researchers across the nation and conducts its own research. It has a $48 billion budget. Kennedy has said he'd pause drug development and infectious disease research to shift the focus to chronic diseases. He'd like to keep NIH funding from researchers with conflicts of interest, and criticized the agency in 2017 for what he said was not doing enough research into the role of vaccines in autism — an idea that has long been debunked . ___ Associated Press writers Amanda Seitz and Matt Perrone and AP editor Erica Hunzinger contributed to this report. ___ The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Science and Educational Media Group and the Robert Wood Johnson Foundation. The AP is solely responsible for all content. Mike Stobbe, The Associated PressBy MICHAEL R. SISAK and JENNIFER PELTZ NEW YORK (AP) — President-elect Donald Trump’s lawyers urged a judge again Friday to throw out his hush money conviction, balking at the prosecution’s suggestion of preserving the verdict by treating the case the way some courts do when a defendant dies. They called the idea “absurd.” Related Articles National Politics | Trump wants to turn the clock on daylight saving time National Politics | Ruling by a conservative Supreme Court could help blue states resist Trump policies National Politics | A nonprofit leader, a social worker: Here are the stories of the people on Biden’s clemency list National Politics | Nancy Pelosi hospitalized after she ‘sustained an injury’ on official trip to Luxembourg National Politics | Veteran Daniel Penny, acquitted in NYC subway chokehold, will join Trump’s suite at football game The Manhattan district attorney’s office is asking Judge Juan M. Merchan to “pretend as if one of the assassination attempts against President Trump had been successful,” Trump’s lawyers wrote in a blistering 23-page response. In court papers made public Tuesday, District Attorney Alvin Bragg’s office proposed an array of options for keeping the historic conviction on the books after Trump’s lawyers filed paperwork earlier this month asking for the case to be dismissed. They include freezing the case until Trump leaves office in 2029, agreeing that any future sentence won’t include jail time, or closing the case by noting he was convicted but that he wasn’t sentenced and his appeal wasn’t resolved because of presidential immunity. Trump lawyers Todd Blanche and Emil Bove reiterated Friday their position that the only acceptable option is overturning his conviction and dismissing his indictment, writing that anything less will interfere with the transition process and his ability to lead the country. The Manhattan district attorney’s office declined comment. It’s unclear how soon Merchan will decide. He could grant Trump’s request for dismissal, go with one of the prosecution’s suggestions, wait until a federal appeals court rules on Trump’s parallel effort to get the case moved out of state court, or choose some other option. In their response Friday, Blanche and Bove ripped each of the prosecution’s suggestions. Halting the case until Trump leaves office would force the incoming president to govern while facing the “ongoing threat” that he’ll be sentenced to imprisonment, fines or other punishment as soon as his term ends, Blanche and Bove wrote. Trump, a Republican, takes office Jan. 20. “To be clear, President Trump will never deviate from the public interest in response to these thuggish tactics,” the defense lawyers wrote. “However, the threat itself is unconstitutional.” The prosecution’s suggestion that Merchan could mitigate those concerns by promising not to sentence Trump to jail time on presidential immunity grounds is also a non-starter, Blanche and Bove wrote. The immunity statute requires dropping the case, not merely limiting sentencing options, they argued. Blanche and Bove, both of whom Trump has tabbed for high-ranking Justice Department positions, expressed outrage at the prosecution’s novel suggestion that Merchan borrow from Alabama and other states and treat the case as if Trump had died. Blanche and Bove accused prosecutors of ignoring New York precedent and attempting to “fabricate” a solution “based on an extremely troubling and irresponsible analogy between President Trump” who survived assassination attempts in Pennsylvania in July and Florida in September “and a hypothetical dead defendant.” Such an option normally comes into play when a defendant dies after being convicted but before appeals are exhausted. It is unclear whether it is viable under New York law, but prosecutors suggested that Merchan could innovate in what’s already a unique case. “This remedy would prevent defendant from being burdened during his presidency by an ongoing criminal proceeding,” prosecutors wrote in their filing this week. But at the same time, it wouldn’t “precipitously discard” the “meaningful fact that defendant was indicted and found guilty by a jury of his peers.” Prosecutors acknowledged that “presidential immunity requires accommodation” during Trump’s impending return to the White House but argued that his election to a second term should not upend the jury’s verdict, which came when he was out of office. Longstanding Justice Department policy says sitting presidents cannot face criminal prosecution . Other world leaders don’t enjoy the same protection. For example, Israeli Prime Minister Benjamin Netanyahu is on trial on corruption charges even as he leads that nation’s wars in Lebanon and Gaza . Trump has been fighting for months to reverse his May 30 conviction on 34 counts of falsifying business records . Prosecutors said he fudged the documents to conceal a $130,000 payment to porn actor Stormy Daniels to suppress her claim that they had sex a decade earlier, which Trump denies. In their filing Friday, Trump’s lawyers citing a social media post in which Sen. John Fetterman used profane language to criticize Trump’s hush money prosecution. The Pennsylvania Democrat suggested that Trump deserved a pardon, comparing his case to that of President Joe Biden’s pardoned son Hunter Biden, who had been convicted of tax and gun charges . “Weaponizing the judiciary for blatant, partisan gain diminishes the collective faith in our institutions and sows further division,” Fetterman wrote Wednesday on Truth Social. Trump’s hush money conviction was in state court, meaning a presidential pardon — issued by Biden or himself when he takes office — would not apply to the case. Presidential pardons only apply to federal crimes. Since the election, special counsel Jack Smith has ended his two federal cases , which pertained to Trump’s efforts to overturn his 2020 election loss and allegations that he hoarded classified documents at his Mar-a-Lago estate. A separate state election interference case in Fulton County, Georgia, is largely on hold. Trump denies wrongdoing in all. Trump had been scheduled for sentencing in the hush money case in late November. But following Trump’s Nov. 5 election victory, Merchan halted proceedings and indefinitely postponed the former and future president’s sentencing so the defense and prosecution could weigh in on the future of the case. Merchan also delayed a decision on Trump’s prior bid to dismiss the case on immunity grounds. A dismissal would erase Trump’s conviction, sparing him the cloud of a criminal record and possible prison sentence. Trump is the first former president to be convicted of a crime and the first convicted criminal to be elected to the office.

As we gathered this Thanksgiving, it was easy to take abundance for granted. Leftovers are practically guaranteed. It wasn’t always this way. For most of history, there were no Thanksgiving feasts. Hunger, if not starvation, was the norm. Today, supermarkets are stocked with exotic foods from all over the world. Most of it is more affordable than ever. Even after President Joe Biden’s 8% inflation, Americans spend less than 12% of our income on food, half of what they spent 100 years ago. Why? Because free markets happened. Capitalism happened. When there is rule of law and private property, and people feel secure that no thief or government will take their property, farmers find new ways to grow more on less land. Greedy entrepreneurs lower costs and deliver goods faster. Consumers have better options. Yet today many Americans trash capitalism, demanding government “fixes” to make sure everyone gets equal amounts of this and that. But it’s in countries with the most government intervention where there are empty store shelves and hungrier people. In socialist Venezuela, affordable food is hard to find. In Cuba, government was going to make everything plentiful. But people suffered so much that, to prevent starvation, the Castros broke from communist principles and rented out state-owned land to private capitalists. Millions still go hungry around the world. The cause is rarely drought or “income inequality” or colonialism, but government control. Corruption, tariffs, political self-dealing and short-sighted regulations block food from reaching those who need it most. Last week, we celebrated the Pilgrims, who learned this lesson the hard way. When they first landed in America, they tried communal living. The harvest was shared equally. That seemed fair. But it failed miserably. A few Pilgrims worked hard, but others didn’t, claiming “weakness and inability,” as William Bradford, the governor of the colony, put it. They nearly starved. Desperate, Bradford tried another approach. “Every family,” he wrote, “was assigned a parcel of land.” Private property! Capitalism! Suddenly, more pilgrims worked hard. Of course they did. Now they got to keep what they made. Bradford wrote, “It made all hands very industrious.” He spelled out the lesson “The failure of this experiment of communal service, which was tried for several years, and by good and honest men proves the emptiness of the theory ... taking away of private property, and the possession of it in community ... would make a state happy and flourishing.” Fast forward 400 years, and many Americans have forgotten what Bradford learned. I see why socialism is popular. The idea of one big, harmonious collective feels good. But it brings disaster. Family dinners already have plenty of disagreements — children fight; adults bicker. Imagine what that would be like among millions of strangers. Collectivist systems encourage dependency, stifle initiative and waste resources. The same communal conceit that nearly starved the Pilgrims destroyed lives in the Soviet Union and led to mass starvation in China. When everyone is forced into the same plan, most people will take as much as they can and produce as little as they can get away with. Economists call it the “tragedy of the commons” referring to a common plot of land, controlled by, say, sheep owners. Each has an incentive to breed more sheep, which then eat the common’s grass until all of it is gone, and everyone goes hungry. Only when the commons is divided into private property does each owner agree to limit his herd’s grazing so there will be enough for his sheep to eat tomorrow. These same principles apply to many aspects of our lives: We thrive when individuals have a deed to their property and are confident that they can keep what they create. Then they create more. That’s what the Pilgrims learned: Incentives matter. Capitalist ownership is what creates American abundance. Every Thanksgiving, I’m thankful for free markets and private property. They are the ingredients of prosperity.Ted (Edward) Frederick, 51, of Pittsfield, died after a brief illness on November 22, 2024, with his son by his side. He was born in Oneonta, N.Y., on October 6, 1973, to Linda and Irving Frederick (deceased). Ted was the son of Linda and Jim Trepanier. He grew up in Lowell, Mass., and was a 1991 graduate from Bishop Guertin High School, where he met his lifetime friend, Mark. After high school, Ted attended Babson College in Boston, where he found brotherhood with another lifelong friend, Kyle, and the rest of the Theta Chi fraternity. At the wedding of one of his brothers he met his love, Susan. They married in 1999. Ted relocated to the Berkshires to start a family, where he began working in information technology at CompuWorks. Ted rose through the Microsoft ranks almost effortlessly. Ready for the next challenge, in “Y2K” he started his own business, Ascentek Technology, which he ran for 20 years. Ascentek gave him more opportunities for kinship with his business relationships. This year, he merged with Synagex Modern IT, where he worked as their chief technology officer, adding to their company culture. Ted was a storyteller, charming almost everyone he met with a clever joke or well-timed magic trick. He enjoyed the spontaneous. A perpetual hobbyist, Ted was always collecting new skills. Whether he was mastering magic and mentalism, teaching poker, or discovering woodworking and 3D printing, he was always willing to try something new and believed he could teach himself anything. Ted was also a movie buff and loved watching films, especially when sharing them with his son. Additionally, he was a voracious reader and could always be found tackling multiple books at once. His eclectic taste in music was evident in his record collection as well as the numerous recommendations he gave to everyone in his life. Ted is survived by his son Jack; his former wife of 20 years Susan; his stepfather and mother, James and Linda Trepanier; his surrogate brothers from Theta Chi; and all of the fast friends he made across Berkshire County and beyond.... “To know him was to love him.” A memorial service will be held on Saturday, November 30, at 11 a.m., at the Church on the Hill in Lenox, with Rev. Liz Goodman officiating. Calling hours will be held on Friday, November 29, from 5 to 7 p.m., at the Roche Funeral Home, 120 Main Street, Lenox. As a longtime business owner, Ted enjoyed supporting many organizations, especially his son’s teams and clubs. With this in mind, donations in Ted’s memory may be made to Lenox Public Schools, in care of the funeral home. To share memories and stories, please visit the funeral home’s website .Scholastic Corporation Announces Third Quarter Dividend

Prospera Financial Services Inc Increases Stock Position in Welltower Inc. (NYSE:WELL)NEW YORK , Dec. 3, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Cassava Sciences, Inc. ("Cassava" or the "Company") (NASDAQ: SAVA ). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980. The investigation concerns whether Cassava and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. [Click here for information about joining the class action] On November 25, 2024 , Cassava issued a press release announcing that its drug simufilam had failed to meet each of the pre-specified co-primary, secondary and exploratory biomarker endpoints in a Phase 3 study evaluating simufilam 100 mg tablets versus placebo over 52 weeks for the treatment of mild-to-moderate Alzheimer's disease ("AD"). In light of these disappointing results, Cassava also announced that it was discontinuing a second Phase 3 trial of simufilam 100 mg and 50 mg tablets versus placebo over 76 weeks for the treatment of mild-to-moderate AD. On this news, Cassava's stock price fell $22.19 per share, or 83.78%, to close at $4.30 per share on November 25, 2024 . Pomerantz LLP, with offices in New York , Chicago , Los Angeles , London , Paris , and Tel Aviv , is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz , known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz continues in the tradition he established, fighting for the rights of the victims of securities fraud , breaches of fiduciary duty, and corporate misconduct. The Firm has recovered billions of dollars in damages awards on behalf of class members. See www.pomlaw.com . Attorney advertising. Prior results do not guarantee similar outcomes. CONTACT: Danielle Peyton Pomerantz LLP [email protected] 646-581-9980 ext. 7980 SOURCE Pomerantz LLP

ELON (3-2) Adams 1-3 2-4 4, Anderson 1-7 4-6 6, Doty 0-2 0-0 0, Pass 2-3 1-2 5, Preston 6-11 1-2 14, Dereje 2-3 0-0 4, Wadkovsky 0-0 0-0 0, Angel 7-13 3-5 20, Ervin 3-6 3-4 10, Khalil 0-0 0-0 0, Morrow 0-1 3-4 3, Shaw 0-0 3-3 3, Walton 0-1 0-0 0, Willard 0-2 0-0 0, Totals 22-52 20-30 69 VIRGINIA TECH (5-1) Baker 3-7 1-2 7, Micheaux 8-12 3-7 19, Ekh 5-12 2-2 16, Wenzel 2-10 6-8 11, Lani White 2-7 2-2 7, Ramiya White 0-1 0-0 0, Nelson 5-7 2-2 12, Petersen 2-6 0-0 4, Suffren 2-2 2-2 6, Wells 2-3 1-1 5, Totals 31-67 19-26 87 3-Point Goals_Elon 5-15 (Anderson 0-2, Preston 1-3, Angel 3-7, Ervin 1-2, Willard 0-1), Virginia Tech 6-18 (Baker 0-2, Ekh 4-8, Wenzel 1-4, L.White 1-1, Nelson 0-1, Petersen 0-2). Assists_Elon 9 (Pass 4), Virginia Tech 21 (Micheaux 10). Fouled Out_Elon Adams, Virginia Tech Suffren. Rebounds_Elon 30 (Angel 6, Preston 6), Virginia Tech 42 (Micheaux 14). Total Fouls_Elon 21, Virginia Tech 19. Technical Fouls_None. A_5,156.HOUSTON (AP) — An elaborate parody appears to be behind an effort to resurrect Enron, the Houston-based energy company that exemplified the worst in American corporate fraud and greed after it went bankrupt in 2001. If its return is comedic, some former employees who lost everything in Enron’s collapse aren’t laughing. “It’s a pretty sick joke and it disparages the people that did work there. And why would you want to even bring it back up again?” said former Enron employee Diana Peters, who represented workers in the company’s bankruptcy proceedings. Here’s what to know about the history of Enron and the purported effort to bring it back. Once the nation’s seventh-largest company, Enron filed for bankruptcy protection on Dec. 2, 2001, after years of accounting tricks could no longer hide billions of dollars in debt or make failing ventures appear profitable. The energy company's collapse put more than 5,000 people out of work and wiped out more than $2 billion in employee pensions. Its aftershocks were felt throughout the energy sector. Twenty-four Enron executives , including former CEO Jeffrey Skilling , were convicted for their roles in the fraud. Enron founder Ken Lay’s convictions were vacated after he died of heart disease following his 2006 trial. On Monday — the 23rd anniversary of the bankruptcy filing — a company representing itself as Enron announced in a news release it was relaunching as a “company dedicated to solving the global energy crisis.” It also posted a video on social media, advertised on at least one Houston billboard and a took out a full-page ad in the Houston Chronicle In the minute-long video full of generic corporate jargon, the company talks about “growth” and “rebirth.” It ends with the words, “We’re back. Can we talk?” In an email, company spokesperson Will Chabot said the new Enron was not doing any interviews yet, but "We’ll have more to share soon.” Signs point to the comeback being a joke. In the “terms of use and conditions of sale” on the company's website, it says “the information on the website about Enron is First Amendment protected parody, represents performance art, and is for entertainment purposes only.” Documents filed with the U.S. Patent and Trademark Office show College Company, an Arkansas-based LLC, owns the Enron trademark. The co-founder of College Company is Connor Gaydos, who helped create a joke conspiracy theory claiming all birds are actually government surveillance drones. Peters said she and some other former employees are upset and think the relaunch was “in poor taste.” “If it’s a joke, it’s rude, extremely rude. And I hope that they realize it and apologize to all of the Enron employees,” Peters said. Peters, 74, said she is still working in information technology because “I lost everything in Enron, and so my Social Security doesn’t always take care of things I need done.” “Enron’s downfall taught us critical lessons about corporate ethics, accountability, and the consequences of unchecked ambition. Enron’s legacy was the employees in the trenches. Leave Enron buried,” she said. But Sherron Watkins, Enron’s former vice president of corporate development and the main whistleblower who helped uncover the scandal, said she didn’t have a problem with the joke because comedy “usually helps us focus on an uncomfortable historical event that we’d rather ignore.” “I think we use prior scandals to try to teach new generations what can go wrong with big companies,” said Watkins, who still speaks at colleges and conferences about the Enron scandal. This story was corrected to fix the spelling of Ken Lay’s first name, which had been misspelled “Key.” Follow Juan A. Lozano on X at https://x.com/juanlozano70Prospera Financial Services Inc Decreases Stake in Northrop Grumman Co. (NYSE:NOC)

Holiday shopping doesn't have to be stressful

Digi International Announces the Nomination of Two Accomplished Executives to its Board of Directors and the Pending Retirement of Sally Smith from the Board of DirectorsBroker says this ASX 200 share offers 'compelling value' for investorsANGOLA, N.Y., Dec. 11, 2024 (GLOBE NEWSWIRE) -- This year marks the 30th anniversary of a game-changing technological breakthrough in the world of telecommunications: TX RX Systems' Tower Top Amplifier (TTA) patent. Developed by TX RX's engineers under founder Daniel P. Kaegebein and first patented in 1986, the Tower Top Amplifier has since become a crucial component in communication systems worldwide, enhancing signal strength, reducing noise, and improving the overall reliability of communication networks. The Tower Top Amplifier was invented to address a fundamental issue in wireless communication: signal loss between the antenna and the receiver due to long coaxial cable runs. The TTA optimizes system performance by placing low-noise amplifiers (LNAs) close to the receiving antenna, significantly reducing interference and maintaining signal integrity. This pioneering solution paved the way for more reliable communications in critical industries such as public safety, telecommunications, and emergency response, and it remains a cornerstone technology in modern communication systems. The Birthplace of Innovation This technological breakthrough originated right here in Angola, NY, where TX RX Systems' engineers sought to solve a persistent challenge faced by radio networks, overcoming interference and minimizing noise in signal transmission. This task required not only a deep understanding of RF technology but also forward-thinking ingenuity that led to the creation of the Tower Top Amplifier. Thirty years later, this once-groundbreaking innovation has become a standard solution for communication towers and networks globally, underpinning critical communication systems from urban centers to remote areas. A Legacy of Technological Advancements Over the years, TX RX Systems has continued to push the boundaries of RF technology, securing several other patents that have had a transformative impact on the industry. Among these innovations is the Bi-directional Filter System, which enables the amplification of signals in separate frequency bands, and the Notch Filter Network, designed to isolate and eliminate unwanted frequencies with precision. These advancements are now widely used in sectors ranging from government to commercial telecommunications. Additionally, TX RX Systems developed the Parallel Fed Collinear Antenna Array, enhancing multi-frequency transmission, and the Temperature Compensation Apparatus, which stabilizes frequency performance in varying environmental conditions. Each of these innovations has further cemented the company's reputation as a leader in RF infrastructure, contributing to the reliability of critical communication systems worldwide. The Global Reach of Local Innovation TX RX Systems' patented technologies are not only used in local and national communication infrastructures but also serve as the backbone of global communication systems. These innovations ensure that vital industries—such as public safety, transportation, and healthcare—are equipped with the tools they need to maintain secure, efficient communication channels in any scenario. The 30-year anniversary of the Tower Top Amplifier is a testament to TX RX Systems' long-standing commitment to technological excellence and innovation. This milestone celebrates not just a single invention but a legacy of ingenuity that continues to shape the future of communication technologies worldwide. About TX RX Systems For nearly 50 years, TX RX has been at the forefront of the Land Mobile Radio (LMR) market, developing mission-critical RF conditioning products and services that support industries such as public safety, telecommunications, and government. With an emphasis on innovation and quality, TX RX continues to lead the industry with cutting-edge technologies designed to enhance communication reliability and performance. For more information about TX RX Systems and its patented technologies, visit www.txrx.com/patents Media Contact: Jay Slomba Director of Business Development & Strategic Marketing jslomba@txrx.com Direct: 716-217-3117 © 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.